Preferred Label : filgotinib;
Origin ID : M000626064;
ATC code(s)
Currated CISMeF NLP mapping
Related record
https://www.has-sante.fr/jcms/p_3486160/fr/jyseleca-filgotinib-rectocolite-hemorragique-rch
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
filgotinib
adult
evaluation of the transparency committee
colitis, ulcerative
filgotinib
---
https://ansm.sante.fr/tableau-marr/filgotinib
2023
false
false
false
France
French
guidelines for drug use
risk management
filgotinib
administration, oral
patient education handout
filgotinib
filgotinib
Janus Kinase Inhibitors
adult
aged
pregnancy
breast feeding
Janus Kinase Inhibitors
arthritis, rheumatoid
---
https://www.has-sante.fr/jcms/p_3412613/fr/jyseleca-filgotinib-rectocolite-hemorragique-et-polyarthrite-rhumatoide
2023
false
false
false
France
filgotinib
insurance, health, reimbursement
treatment outcome
adult
administration, oral
Janus Kinase Inhibitors
evaluation of the transparency committee
filgotinib
colitis, ulcerative
arthritis, rheumatoid
---
https://www.has-sante.fr/jcms/p_3343855/fr/jyseleca-filgotinib-rectocolite-hemorragique
2022
false
false
false
France
filgotinib
filgotinib
Filgotinib Maleate
adult
female
treatment outcome
insurance, health, reimbursement
administration, oral
evaluation of the transparency committee
colitis, ulcerative
---
https://www.has-sante.fr/jcms/p_3242562/jyseleca
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
filgotinib
filgotinib
filgotinib
administration, oral
female
arthritis, rheumatoid
Janus Kinase Inhibitors
Janus Kinase Inhibitors
evaluation of the transparency committee
GLPG0634
GLPG0634
pyridines
triazoles
pyridines
triazoles
---
https://www.ema.europa.eu/en/medicines/human/EPAR/jyseleca
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
filgotinib
filgotinib
filgotinib
adult
arthritis, rheumatoid
administration, oral
drug therapy, combination
methotrexate
Janus Kinase Inhibitors
Janus Kinase Inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
GLPG0634
GLPG0634
pyridines
triazoles
pyridines
triazoles
---